Charles A Phillips
Overview
Explore the profile of Charles A Phillips including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grenier J, Tasian S, Stieglitz E, Abdullaev Z, Wertheim G, Li M, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31647.
PMID: 40040253
No abstract available.
2.
Marks L, Ritter V, Agrusa J, Agrusa J, Kamdar K, Rivers J, et al.
Blood Adv
. 2025 Jan;
9(6):1356-1365.
PMID: 39841960
Treatment options for patients with relapsed or refractory (R/R) anaplastic large cell lymphoma (ALCL) have increased in the era of targeted therapies such as brentuximab vedotin (BV) and anaplastic lymphoma...
3.
Phillips C, Kennelly R, Carroll C, Gibson F, Elgarten C, Orsey A, et al.
Support Care Cancer
. 2024 Sep;
32(10):644.
PMID: 39243282
Purpose: Malnutrition is common in children with cancer. While multiple validated malnutrition screens exist, there is no universal, standardized approach to screen or diagnose malnutrition. The Multinational Association of Supportive...
4.
Wyatt K, Alexander N, Hills G, Liang W, Kadauke S, Volchenboum S, et al.
Pediatr Blood Cancer
. 2024 Jun;
71(9):e31143.
PMID: 38924670
ChatGPT and other artificial intelligence (AI) systems have captivated the attention of healthcare providers and researchers for their potential to improve care processes and outcomes. While these technologies hold promise...
5.
Wolfset N, Pashmineh Azar A, Phillips C, Stein M, Rheingold S, Heimall J, et al.
J Pediatr Hematol Oncol
. 2024 Jan;
46(2):e202-e204.
PMID: 38181327
Polyethylene glycol-asparaginase (PEGAsp) is an established component of acute leukemia therapy. Hypersensitivity reactions to PEGAsp occur in 10% to 15% of patients, with polyethylene glycol suggested as the antigenic culprit....
6.
Freedman J, Beeler D, Bowers A, Bradford N, Cheung Y, Davies M, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067252
The optimization of outcomes for pediatric cancer patients relies on the successful advancement of supportive care to ease the treatment burden and mitigate the long-term impacts of cancer therapy. Advancing...
7.
Mehta S, Congdon M, Phillips C, Galligan M, Hanna C, Muthu N, et al.
J Hosp Med
. 2023 May;
18(6):509-518.
PMID: 37143201
Background: Late recognition of in-hospital deterioration is a source of preventable harm. Emergency transfers (ET), when hospitalized patients require intensive care unit (ICU) interventions within 1 h of ICU transfer,...
8.
Anderson D, Hanna R, Azar A, Collier V, Hankins P, Loudon B, et al.
Transplant Cell Ther
. 2023 Jan;
29(3):207.e1-207.e5.
PMID: 36610491
Institutions that perform hematopoietic cell transplantation (HCT) are required by law to report standardized, structured data on transplantation outcomes. A key post-transplantation outcome is engraftment, the time between HCT infusion...
9.
Wyatt K, Noyd D, Wood N, Phillips C, Miller T, Rubin E, et al.
Pediatr Blood Cancer
. 2022 Dec;
70(2):e30128.
PMID: 36495256
In this commentary, we highlight the central role that data standards play in facilitating data-driven efforts to advance research in pediatric oncology. We discuss the current state of data standards...
10.
Phillips C, Barakat L, Pollock B, Bailey L, Beidas R
Pediatr Blood Cancer
. 2022 Jan;
69(4):e29579.
PMID: 35044081
Implementation science (IS) has garnered attention within oncology, and most prior IS work has focused on adult, not pediatric, oncology. This narrative review broadly characterizes IS for pediatric oncology. It...